论文部分内容阅读
目的 观察联合门静脉切除在肝门部胆管癌治疗中的作用,以进一步提高肝门胆管癌的治疗效果。方法 总结1990年3 月至2002 年3 月我院收治的78 例肝门部胆管癌的临床资料。结果 本组联合门静脉切除12例,其中门静脉分叉部联合左半肝切除3例,门静脉主干切除6例,门静脉侧壁切除修补术3例;术后肝肠吻合口漏、肝功能衰竭死亡1例;其余11例病人术后随访6 个月至6年,平均19个月,其中最长的1例已存活6年。结论 联合门静脉切除可提高肝门部胆管癌的治愈切除率,改善术后病人预后。
Objective To observe the role of combined portal vein resection in the treatment of hilar cholangiocarcinoma to further improve the therapeutic effect of hilar cholangiocarcinoma. Methods The clinical data of 78 cases of hilar cholangiocarcinoma admitted to our hospital from March 1990 to March 2002 were summarized. Results In this group, 12 cases were treated with portal vein resection, including 3 cases with portal vein bifurcation and left hepatectomy, 6 cases with portal vein resection and 3 cases with portal vein resection and repair. One patient died of hepatico-intestinal anastomotic leakage and hepatic failure after operation ; The remaining 11 patients were followed up for 6 months to 6 years, an average of 19 months, of which the longest one has survived 6 years. Conclusions Combined portal vein resection can improve the cure rate of hilar cholangiocarcinoma and improve the prognosis of postoperative patients.